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ABSTRACT
The loss of telomere function can result in the fusion
of telomeres with other telomeric loci, or non-
telomeric double-stranded DNA breaks. Sequence
analysis of fusion events between short dysfunc-
tional telomeres in human cells has revealed
that fusion is characterized by a distinct molecular
signature consisting of extensive deletions and
micro-homology at the fusion points. This signature
is consistent with alternative error-prone end-
joining processes. We have examined the role that
Mre11 may play in the fusion of short telomeres
in human cells; to do this, we have analysed
telomere fusion events in cells derived from
ataxia-telangiectasia-like disorder (ATLD) patients
that exhibit hypomorphic mutations in MRE11.
The telomere dynamics of ATLD fibroblasts were
indistinguishable from wild-type fibroblasts and
they were proficient in the fusion of short telomeres.
However, we observed a high frequency of insertion
of DNA sequences at the fusion points that created
localized sequence duplications. These data
indicate that Mre11 plays a role in the fusion of
short dysfunctional telomeres in human cells and
are consistent with the hypothesis that as part of
the MRN complex it serves to stabilize the joining
complex, thereby controlling the fidelity of the
fusion reaction.
INTRODUCTION
Mammalian telomeres are comprised of TTAGGG
repeats terminating in a single-stranded G-rich overhang
at the terminus. The shelterin protein complex, which
includes six core proteins, protects telomeres from
aberrant non-homologous end joining and fusion (1).
Telomeres rendered dysfunctional by the removal of
TRF2 or by replicative erosion of telomeres are
recognized as double-strand breaks (DSBs) activating
both ataxia telangiectasia mutated (ATM) and ataxia tel-
angiectasia and Rad3-related (ATR) kinase-dependent
DNA damage response pathways (2–4). The Mre11
protein constitutes the core of the mammalian Mre11/
Rad50/Nbs1 complex (MRN) (5,6) and is required for
ATM signalling and the coordination of the DNA
damage response to DSBs and telomere dysfunction (7).
Mre11 exhibits structure-speciﬁc 30–50 exonuclease and
endonuclease activities and controls the initiation of
50–30 resection (8–10). The DNA-binding activity of
Mre11 brings DSBs together in order to facilitate repair
(8,11,12). Mre11 is thus a key player in the major double
DNA break repair pathways: homologous recombination
and non-homologous end joining. Mre11 activity has
also been implicated in end processing for micro-
homology-mediated end joining (MMEJ). MMEJ is an
error-prone Ku-independent non-homologous end-joining
pathway that can lead to large-scale deletion events,
presumably as a consequence of extensive nucleolytic
resection of the broken ends (13–16). These alternative
end-joining (A-EJ) processes are also associated with
chromosome translocations and rearrangements in the
absence of p53 (17) as well in class switch recombination
(CSR) (18,19). The absence of Mre11 results in aberrant
switch recombination junctions following CSR with
increased micro-homology and additional sequences
inserted at the junction point (20).
Telomere fusion is observed following the experimental
abrogation of the shelterin component TRF2; in this situ-
ation telomere fusion is immediate and dependent on the
key components of NHEJ include ligase IV and DNA-PK
(21,22). Gradual replicative telomere erosion, as well telo-
meric deletion, results in short dysfunctional telomeres
that can be subjected to fusion with other telomeres or
non-telomeric double-stranded DNA breaks. This has
been observed in experimental situations following the
abrogation of the p53-dependent checkpoint responses
where complete telomere loss leads to extensive telomere
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been observed sporadically in normal cells (24) and during
neoplastic progression (25). Direct sequence analysis of
fusions derived from normal cells, cells undergoing crisis
and cells derived from normal and neoplastic tissues has
revealed a distinct mutational proﬁle that accompanies
telomere fusion (24–26). This consisted of signiﬁcant
micro-homology, similar to that observed at CSR junc-
tions (19) and a G:C bias at the fusion point. Strikingly,
all fusion events involved the deletion of one or both of
the participating telomeres. The deletion events extended
into the sub-telomeric DNA up to the limit of the assays
(6kb), the proﬁle of sub-telomeric deletion indicated that
deletion may extend beyond the limit of these assays
(24,26). The mutational proﬁle that accompanies the
fusion of short dysfunctional telomeres in human cells is
consistent with Ku-independent error-prone A-EJ
processes. This is also supported by observations in
Arabidopsis, mice and yeast that show short telomeres
can undergo fusion in the absence of functional NHEJ
(27–29). Given the role that Mre11 plays in end joining
and its possible involvement with A-EJ processes, here we
have investigated its role in mediating the fusion of short
dysfunctional telomeres in human cells. To do this we
have analysed telomere fusion events in cells derived
from ataxia telangiectasia-like disorder (ATLD) patients
that exhibit hypomorphic mutations in MRE11. The
mutation in ATLD3/4 is characterized by full-length
mutant hMre11 expressed from paternal allele with a
miss-sense mutation at 350A/G, resulting in a 117 N/S
amino acid change, and nonsense-mediated mRNA
decay operating on the transcripts from the maternal
allele (30,31). ATLD cells display impaired activation of
the S phase DNA damage checkpoint, exhibit hypersensi-
tivity to ionizing radiation and show an increased level
of chromosome translocations in the peripheral blood
(30–32). Here, we describe an analysis of telomere




ATLD1, 2, 3 and 4 cells (31) were cultured in Dulbecco’s
modiﬁed Eagle’s medium (DMEM) supplemented with
10% fetal bovine serum (Invitrogen), 100U/ml penicillin,
100mg/ml streptomycin (Invitrogen) and 2mM
L-glutamine (Invitrogen). Primary cultures were infected
at PD 7 (ATLD2 and 3) and at PD11 (ATLD4) with
amphotropic retroviral vectors expressing HPV 16 E6E7
oncoproteins and selected with G418 (0.4mg/ml) as
described previously (33). Cells also were infected with
retroviral empty vector pBabeNeo and used as a
negative control in our study.
DNA extraction and single telomere length analysis
Genomic DNA from cells was extracted using standard
proteinase K/phenol/chloroform protocols (34). For
telomere length analysis at 17p and XpYp, including
allele-speciﬁc XpYp analysis, we used the modiﬁed
STELA protocol (24,34).
Telomere fusion assay
For analysis of telomere fusions we used a protocol and
oligonucleotides described previously (24,26). Polymerase
chain reaction (PCR) reactions with 17p6, XpYpM and
21q1group primers were performed to detect fusion
products between 17p, XpYp and 21q group chromo-
somes with between 10 and 40ng of DNA per reaction.
All subsequent Southern blot hybridizations were carried
out with random-primed [a
33P]-labelled XpYp, 17p and
21q telomere-adjacent probes (24,26).
RESULTS
Telomere dynamics in ATLD cells
To study the role of Mre11 in telomere fusion we used
primary ﬁbroblasts cultures derived from ATLD
patients. ATLD1, 2 3 and 4 cells express wild-type p53
and pRb (31). In order to inactivate the function of
these major tumour suppressor genes, bypass replicative
senescence and facilitate continued telomere erosion, the
ATLD cells were transfected with human papilloma virus
(HPV) 16 E6E7 oncoproteins. The abrogation of p53 and
pRb extended the replicative life span by up to 19–24 PDs
for ATLD4 E6E7 and ATLD3 E6E7, respectively. The
empty vector controls underwent replicative senescence
at PD15 in ATLD3 and at PD16 in ATLD4
(Supplementary Figure S1). The bulk population of cells
reached crisis at PD27 (ATLD3) and PD30 (ATLD4),
while the four clonal populations of cells surpassed
them, approaching crisis at a maximum of PD 39
(ATLD 3) and PD 35 (ATLD 4, Supplementary Figure
S1). ATLD 1 and 2 cells proliferated poorly in culture
achieving just 0.8 PD and 7.4 PD, respectively, over a
90-day period; HPV E6E7 transfection of these cultures
did not provide any evidence of life-span extension (data
not shown). The lack of proliferation precluded an exam-
ination of telomere dynamics and fusion in ATLD 1 and
2 cells.
Telomere dynamics were monitored in ATLD 3 and
4 cells using single telomere length analysis (STELA),
a high-resolution single-molecule approach to determine
telomere length at speciﬁc chromosome ends (24,34,35).
Analysis of the XpYp and 17p telomere revealed that
the telomere dynamics of ATLD 3 and 4 ﬁbroblasts
were indistinguishable from those observed in normal
primary diploid ﬁbroblast cell strains. The mean rate
of erosion at the 17p and XpYp telomere was 73
and 97bp/PD for ATLD 3 and 4, respectively
(Figure 1A and Supplementary Figure S2A) within the
range of erosion rates in normal ﬁbroblast cultures
(63±39bp/PD, mean±SD) documented previously
using STELA (34). The expression of HPV E6E7
facilitated ongoing cell division and continued telomere
erosion beyond the point of replicative senescence.
Consistent with the telomere dynamics observed in cell
populations entering crisis (24), the ATLD E6E7
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erosion (Figure 1A and Supplementary Figure S2A).
The extent of telomere erosion indicated that we would
be able to detect fusion of critically eroded telomeres in
ATLD cells. To characterize fusion events we used a
highly speciﬁc and sensitive single-molecule telomere
fusion assay allowing the identiﬁcation and sequence char-
acterization of telomere fusion events between the XpYp,
17p and a family of telomeres related to the 21q telomere
which includes the following chromosomes: 21q, 1q, 2q,
5q, 6q, 6p, 8p, 10q, 13q, 17q, 19p, 19q and 22q (24,26).
We did not detect fusion in ATLD 3 or 4 cells in the
early stages of the replicative life span of the culture.
However, with ongoing cell division beyond the point of
replicative senescence there was an increasing frequency of
fusions as both the ATLD 3 and 4 cells expressing HPV
E6E7 approached crisis (Figure 1B and Supplementary
Figure S2B). In ATLD3 cells the highest frequency
of fusions was observed at crisis with a maximum fre-
quency of 3 10
 4 which was similar to the frequencies
of fusion observed in MRC5 ﬁbroblasts undergoing
crisis (26). The frequency of fusion in ATLD4 E6E7
was higher, with a maximum frequency of 2.3 10
 3;
this was over 5  higher than that observed in MRC5
cells (26). Fusion was also observed in the clonal
E6E7 populations and the pattern of fusion events
appeared to match the telomere dynamics, with the
appearance of fusion events coinciding with the apparent
loss of telomeric alleles (Figure 1B and Supplementary
Figure S2).
Figure 1. Telomere dynamics and fusion in ATLD4 cells. (A) XpYp and 17p STELA, each sample is analysed with four separate reactions; the
population doubling (PD) point of the culture is indicated above each gel. Mean telomere length, standard deviation and rate of telomere erosion as
a function of PD is indicated below the gel. (B) Telomere fusion analysis, single molecule fusion events are detected by southern hybridization with
the XpYp and 17p telomere-adjacent probes as indicated on the right. The PD points of the cultures are indicated above.
2520 Nucleic Acids Research, 2012,Vol.40, No. 6Taken together, these data indicate that ATLD cells
exhibit normal rates of telomere erosion and that
telomere erosion to critical lengths results in telomere–
telomere fusion.
Telomere fusion in ATLD cells
In order to further examine telomere fusion in ATLD cells
we puriﬁed and characterized the DNA sequence of a total
of 102 independent telomere fusion events in both
ATLD3/4 E6E7 cells. This allowed us to examine the
mutational proﬁle that accompanies telomere fusion in
the ATLD ﬁbroblast cultures and compare this to
similar data sets derived from normal human ﬁbroblast
cultures (24,26).
TTAGGG repeat content, micro-homology and
sub-telomeric deletion
Of the fusion events characterized from ATLD3/4 E6E7
cells 54% did not contain telomere repeats (TTAGGG)n
immediately adjacent to the fusion point (Figure 2A).
Among those that did contain TTAGGG repeats, the
length ranged from 0.17 to 43.17 repeats with a mean
7.9±1.2 (SE), this was not signiﬁcantly different from
that observed using the same assays in MRC5 with
wild-type Mre11 (P=0.37) (26). Again, consistent with
our previous data in Mre11 wild-type cells (P=0.25,
V
2), the ATLD3/4 cells exhibited micro-homology at the
fusion point in 58% of the total number of fusion events
(Figure 2B) which was less than that observed in Mre11
wild-type cells (73%, Figure 2F). The mean length of
micro-homology was 2.3 nucleotides, ranging from 1 to
7 nucleotides, this distribution was not signiﬁcantly
different from Mre11 wild-type cells (P=0.25, V
2). All
fusions in ATLD3/4 E6E7 cells involved the deletion of
one or both telomeres with deletion extending into the
telomere-adjacent DNA up to the limits of the assays
(3.4kb from the telomere repeat array), again the extent
of sub-telomeric deletion was not signiﬁcantly different
from Mre11 wild-type cells (P=0.54 for XpYp and
P=0.08 for 17p) (Figure 2C–E).
Thus, compared to that observed in Mre11 wild-type
cells, telomere fusion in ATLD cells appears to involve
telomeres within the same length range and there was no
detectable difference in the proﬁle of telomere fusion in
terms of micro-homology and sub-telomeric deletion.
Insertion
We have previously documented that telomere fusion can
result in the insertion of sequences from identiﬁable
non-telomeric loci between the two telomeres involved in
the fusion events; these constitute 7–9% of fusion
events in Mre11 wild-type and ATLD cells, respectively
(Figure 2F) (24,26). However, in ATLD cells we observed
an additional class of event that resulted in the insertion
of short tracts of apparently random nucleotides. We
detected these insertions in 15 out of 102 fusion events
sequenced (15%) in ATLD cells, a signiﬁcant increase
on that observed in mre11 wild-type cells where just
3 out of 139 events sequenced where of this type (2%,
P<0.001, Figure 2F).
We examined the sequence of the nucleotide insertions
up to 20nt either side of the breakpoint in the
participating telomeres. This revealed that in 13 of the
15 fusion events that contained nucleotide insertions
(86%), the sequences across the junction, including both
the inserted DNA and nucleotides ﬂanking the break
point, were duplicated in the adjacent DNA of one of
the participating telomeres (Figure 3A). This was also
apparent in the three fusion events of this type observed
in Mre11 wild-type cells, although the insertion size
was smaller (Figure 3B).
Our data allow us to conclude that Mre11 is involved in
the fusion of short dysfunctional telomeres and that
telomere fusion in ATLD 3/4 cells is more error prone,
resulting in insertion and duplication of sequences
around the fusion point.
DISCUSSION
We took advantage of the Mre11 mutations in ATLD cells
to study of the role of this protein in the fusion of short
dysfunctional telomeres. The mutations in ATLD are
hypomorphic and the documented DNA repair defects
in these cells are subtle (31). This may also be reﬂected
in the telomere length analysis of ATLD 3/4 cells
described in this study in which we observed no overt
differences in telomere dynamics. This included the rates
of telomere erosion as a function of population doubling
that were entirely normal. Moreover the telomeres at the
point of senescence in ATLD cells were also within the
normal length range detected in Mre11 wild-type cells
undergoing p53-dependent replicative senescence (34,35).
Furthermore, the expression of HPV E6E7 in ATLD
cells extended the replicative lifespan of these cells by up
to 24 PDs, again this is within the range observed
in Mre11 wild-type cells (24). These data indicate
that ATLD 3/4 cells undergo an otherwise normal
p53-dependent replicative life span; this is consistent
with the observation that ATLD cells exhibit a normal
p53 response to ionizing radiation (31). In contrast,
ATLD 1 and 2 cells exhibited a severely truncated repli-
cative life span; this may reﬂect the more severe phenotype
of these cells speciﬁcally the defective checkpoint
responses to DNA damage (36,37).
The extended replicative life span following the expres-
sion of HPV E6E7 facilitated continued telomere erosion
to a point at which complete telomere loss could be
detected. This was accompanied by an increase in the
frequency of telomere fusion molecules to rates slightly
higher than that observed in Mre11 wild-type cells (26).
Our data on telomere fusion indicate that the expression
of HPV 16 E6E7 does not impact on telomere fusion
(24,25,26). These data show that the mutational
spectrum (deletion size, number of TTAGGG repeats
and micro-homology) of fusion observed in HPV E6E7
ﬁbroblast cultures undergoing ‘crisis’ is indistinguishable
from sporadic fusion events in normal cell cultures in vitro
or during tumour progression in vivo. Thus, we consider
that the fusion of short telomeres following extended
proliferation as a consequence of HPV E6E7 expression
Nucleic Acids Research,2012, Vol.40, No. 6 2521represents a physiologically relevant model. The extent of
sub-telomeric deletion observed in ATLD cells was
indistinguishable from wild-type cells; however, because
ATLD 3/4 contains hypomorphic Mre11 alleles these
data do not allow us to draw any conclusions about the
involvement, or not, of Mre11 nuclease activity in the
DNA resection that may accompany the fusion of short
dysfunctional telomeres. The nuclease activity of Mre11 is
required double-strand DNA break repair (38) and for
telomere fusion in context of TRF2 knockdown in
mouse models (39).
The key observation in our data set was the presence of
additional nucleotides at the telomere fusion points in
ATLD cells. These nucleotide insertions were distinct
from the insertion of clearly identiﬁable loci from else-
where in the genome, as we have previously described in
Mre11 wild-type cells. The insertion of additional nucleo-
tides has also been described at CSR junctions in ATLD
Figure 2. Illustrating the mutational proﬁle that accompanies telomere fusion in ATLD 3/4 cells. (A) The frequency of TTAGGG repeats at the
fusion point. (B) Micro-homology at the fusion point. (C–E) Representing the distance of sub-telomeric deletion from the start of the telomere repeat
arrays of 17p, XpYp and 21q. The extent of sub-telomeric deletion that can be detected with the assays is indicated by a dotted line across the x-axis.
The means±standard error are indicated on each panel. (F) Pie chart displaying the proportions of telomere fusion events displaying sequence
homology, nucleotide insertions and identiﬁable insertions at the fusion point in MRC5 and ATLD 3/4 cells.
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Figure 3. Displaying the DNA sequence at the fusion point in a subset of fusions that display nucleotide insertions in ATLD cells (A) and MRC5
cells (B). The fusion sequence is displayed on the top lines, with the fusion partners displayed below. Arrows indicate the fusion point, the DNA
between the arrows represent the DNA insertions, the participating chromosomes and the deletion sizes are stated above, asterisks below indicate
homology between the fusion partners, sequence highlighted in red and underlined indicate duplicated sequences across the fusion point. No
duplications could be detected in fusions 13 and 15.
Nucleic Acids Research,2012, Vol.40, No. 6 2523cells (20). Together, these data are consistent with the role
of Mre11 in A-EJ processes and that these processes may
underlie the fusion of short dysfunctional telomeres.
An increase in small unidentiﬁed insertions at fused telo-
meres have also been described in Arabidopsis tert ku70
mre11 triple mutants; however, the origin of these se-
quences could not be determined (28). In ATLD cells,
the nucleotide insertions resulted in the duplication of
the adjacent DNA of one of the participating telomeres.
This implies that during the processing of telomere–
telomere fusion events there is DNA synthesis templated
from the adjacent DNA of one of the partner chromo-
somes. The miss-sense mutations within Mre11 in
ATLD 3/4 cells impair Nbs1 binding (6,31) and this may
occur by distorting the surface of Mre11 and interfering
with protein–protein interactions (12). It is apparent that
Mre11 dimerization is stabilised by DNA binding (12).
Thus, in the context of the ATLD 3/4 Mre11 mutations,
the MRN complex may be less stable and less able
to maintain the synapses of the two participating telo-
meres. We consider this may allow for aberrant
DNA synthesis, by, for example, polymerases Pol  and
Polm that are implicated in NHEJ during DNA repair
(40,41). This may serve to increase the localized
homology and base pairing to stabilize the complex
prior to ligation.
The fusion of short dysfunctional telomeres has been
implicated in driving instability during tumour progres-
sion (25). The data presented here allow us to conclude
that, like telomeres rendered dysfunctional by the experi-
mental abrogation of TRF2 (39), the fusion of short
dysfunctional telomeres can involve Mre11 function.
B
Figure 3. Continued.
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